Ceres Inc (CERE) News
Filter CERE News Items
CERE News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
CERE News Highlights
- CERE's 30 day story count now stands at 7.
- Over the past 6 days, the trend for CERE's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
- The most mentioned tickers in articles about CERE are ABBV, DRUG and GME.
Latest CERE News From Around the Web
Below are the latest news stories about CEREVEL THERAPEUTICS HOLDINGS INC that investors may wish to consider to help them evaluate CERE as an investment opportunity.
The 7 Most Undervalued Growth Stocks to Buy in DecemberStocks of a lot of well-known and historically great companies are on sale right now. |
The 3 Best Cheap Stocks to Buy in DecemberInvestors wanting to buy low and sell high should consider a position in one of these great companies whose shares have pulled back lately. |
$19 Billion in a Week: AbbVie Makes Two Big BetsThe drugmaker is doubling down on cancer and neurology as it seeks to replace falling revenue from its top sellers. |
LILM Stock Alert: Lilium Partners Up With LufthansaLilium stock is gaining on Thursday as investors in LILM react to a potential partnership with Lufthansa for eVTOLs in Europe. |
Why Is Cerevel Therapeutics (CERE) Stock Up 12% Today?Cerevel Therapeutics stock is climbing higher as CERE investors react to an $8.7 billion acquisition deal with AbbVie. |
Why Is Cyngn (CYN) Stock Up 73% Today?Cyngn stock is up on Thursday with heavy trading of CYN shares as investors react to news of a new self-driving AI patent. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayIt's time to start off Thursday with a breakdown of the biggest pre-market stock movers worth keeping an eye on this morning! |
Bain Capital Banks Massive Return on Cerevel DealAbbVie’s $8.7 billion purchase is expected to deliver a return of over 10 times invested capital to the buyout firm. |
Stocks to Watch Thursday: AbbVie, AMD, GameStop, Cerevel, JetBlue[**GameStop (GME)**](https://www.wsj.com/market-data/quotes/GME): The videogame retailer reported a [9% sales drop](https://www.wsj.com/livecoverage/stock-market-today-dow-jones-12-06-2023/card/gamestop-sales-drop-9-loss-narrows-on-cost-cuts-Wn9X6ozc38pVmhRbVgOH?mod=lctimeline_finance) for its most-recent quarter. |
AbbVie acquiring Cerevel Therapeutics in $8.7B dealAbbVie (ABBV) announced it is acquiring neuroscience drug developer Cerevel Therapeutics (CERE) for $45.00 per share, putting the deal value at about $8.7 billion. AbbVie Chairman and CEO Richard Gonzalez said in the announcement that the combined portfolios will present a "significant growth opportunity well into the next decade." The deal comes about a week after AbbVie announced it was acquiring cancer drugmaker ImmunoGen (IMGN) for just over $10 billion. Yahoo Finance Healthcare Reporter Anjalee Khemlani breaks down the deal. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. |